Biotech Stock 685% Draws Big Investment Amid FDA Filings
A biotech stock that sprinted 685% in months drew a sizeable institutional bet as it pressed ahead with two FDA filin...
A budget review helps you spot gaps and realign spending with goals. This introduction highlights essential items to include for a clear, actionable assessment.
17,603 articlesA biotech stock that sprinted 685% in months drew a sizeable institutional bet as it pressed ahead with two FDA filin...
Thinking beyond the U.S. market? This guide explains why ixus: this international stock can play a key role in divers...
Healthcare sector ETFs offer defense and income, but not all are created equal. This article dives into how state str...
When a EZCORP director unloads 10,000 shares, investors naturally wonder if it signals trouble or simply a routine di...
In May 2026, a Cohu director disclosed a sizable open-market sale. This article breaks down the numbers, explains For...
A routine trade-in can turn risky when trust is exploited. This article explains how a trusted cellphone clerk handle...
A major biotech investor is stepping up its bet on Krystal Biotech as the company posts robust 2025 revenue. This mov...
Chart Industries just delivered a sweeping earnings milestone, but a sizable investor trimmed a multi-million dollar ...
A fresh stake of roughly $4.5 million by a value-focused firm in Workiva raises questions about what comes next for W...
A new wave of legal challenges has hit kardashian’s skims with lawsuit, shaking up the brand’s polished image. This a...
Choosing the right bank savings account features can unlock higher interest, lower fees, and easier money management....
A director sold a chunk of Ligand Pharmaceuticals stock, prompting questions about intent and impact. This guide brea...